Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 4,148 shares at $189.75 ($797K) on 2021-03-04, disclosed to the SEC on 2021-03-08.
Seasonal sale ($797k) by Chief Financial Officer — this insider has traded RGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.75 | 600 | $114K | 14.3% |
| 2 | $190.45 | 603 | $115K | 14.4% |
| 3 | $190.45 | 603 | $115K | 14.4% |
| 4 | $191.43 | 500 | $96K | 12.0% |
| 5 | $192.54 | 900 | $173K | 21.7% |
| 6 | $193.72 | 242 |
| $47K |
| 5.9% |
| 7 | $196.30 | 500 | $98K | 12.3% |
| 8 | $197.86 | 200 | $40K | 5.0% |
| Total | $192.17 avg | 4,148 | $797K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-01-06 | $1.4M | — | Filing → |